Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

Journal of Immunology

Volumn 166, Issue 12, 2001, Pages 7527-7533

  Tikka, T M ^a   Koistinaho, J E ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; GLUTAMIC ACID; INTERLEUKIN 1BETA CONVERTING ENZYME; ION CHANNEL; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE SYNTHASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; EMBRYO; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035876916     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.12.7527     Document Type: Article

References (57)

1. Pathobiology of ischemic stroke: An integrated view
2. The changing landscape of ischemic brain injury mechanisms
3. Neuroprotection, excitotoxicity and NMDA antagonists
4. 2+-independent synaptic vesicle release
5. Role of NO production in NMDA receptor mediated neurotransmitter release in cerebral cortex
6. 3H-glutamate transport in synaptosomes
7. Peroxynitrite inhibits glutamate transporter subtypes
8. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system
9. Inflammation of the brain in Alzheimer's disease: Implications for therapy
10. Inflammation and Alzheimer's disease
11. Cytokine and protease glycosylation as a regulatory mechanism in inflammation and autoimmunity
12. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
13. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
14. Microglial secretion products and their impact on the nervous system
15. Induction of microglial and astrocytic response in adult rat lumbar spinal cord following middle cerebral artery occlusion
16. Cytokine and free radical production by porcine microglia
17. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures
18. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
19. Magrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines
20. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors
21. Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia
22. Do NMDA antagonists protect against cerebral ischemia: Are clinical trials warranted?
23. Why do neuroprotective drugs work in animals but not humans?
24. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
25. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
26. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
27. Glutamatergic receptors regulate expression, phosphorylation and accumulation of neurofilamanets in spinal cord neurons
28. Brain glia release factors with opposing action upon neuronal survival
29. Expression of ionotrophic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia
30. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia
31. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia
32. Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats
33. Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide
34. Cortical death caused by striatal administration of AMPA and interleukin-1 is mediated by activation of cortical NMDA receptors
35. Interleukin-1 as a pathogenic mediator of ischemic brain damage in rats
36. Inhibition of interleukin 1β converting enzyme family protease reduces ischemic and excitotoxic neuronal damage
37. Nitric oxide and neurons
38. Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide
39. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus
40. Potentiation of N-methyl-D-aspartate-mediated neurotoxicity by immunostimulated murine migroglia
41. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
42. p38 but not p44/42 mitogen activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages
43. Selective inhibition of p38 mitogen activated kinase reduces brain injury and neurological deficits in rat focal stroke models
44. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus
45. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence
46. Extracellular-signal-regulated kinase signaling in neurons
47. MEK1 protein kinase inhibition protects against resulting from focal cerebral ischemia
48. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neuron in a cell-culture model of seizure activity
49. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase
50. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket
51. TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice
52. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways
53. Application of real-time polymerase chain reaction to quantitate induced expression of interleukin- 1β mRNA in ischemic brain tolerance
54. Detection of tumor necrosis factor-α mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction
55. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning
56. Safety of long-term high-dose minocycline in the treatment of acne
57. Safety of minocycline for acne